{
  "id": 208,
  "text": "This resulted in improved stratification of outcome, but hetero­ geneity remained, particularly for patients with stage III disease.Overall, progression-free survival at 5 years by the 2009 FIGO system versus the 2018 FIGO system was: stage I, $8 0 \\%$ versus $8 7 \\%$ $( P = 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: This resulted in improved stratification of outcome, but hetero­ geneity remained, particularly for patients with stage III disease.Overall, progression-free survival at 5 years by the 2009 FIGO system versus the 2018 FIGO system was: stage I, $8 0 \\%$ versus $8 7 \\%$ $( P = 0 .\n\n<question>: ",
  "ChatGPT_response_0": "根据提供的数据，可以观察到2018年FIGO系统相较于2009年FIGO系统在分期III疾病患者中有一些差异。尽管这种更新改进了患者预后的分层，但异质性仍然存在，特别是对于分期III疾病患者。总体上，根据数据显示，2018年FIGO系统相对于2009年FIGO系统的5年无进展生存率分别为：分期I为80%与87%（P=0.）。",
  "query": "根据提供的数据，您觉得2018年FIGO系统相较于2009年FIGO系统在分期III疾病患者中有何不同？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据提供的数据，您觉得2018年FIGO系统相较于2009年FIGO系统在分期III疾病患者中有何不同？\n\n<reference text>: This resulted in improved stratification of outcome, but hetero­ geneity remained, particularly for patients with stage III disease.Overall, progression-free survival at 5 years by the 2009 FIGO system versus the 2018 FIGO system was: stage I, $8 0 \\%$ versus $8 7 \\%$ $( P = 0 .\n\n<reply>: ",
  "response": "根据提供的数据，可以观察到2018年FIGO系统相较于2009年FIGO系统在分期III疾病患者中有一些差异。尽管这种更新改进了患者预后的分层，但异质性仍然存在，特别是对于分期III疾病患者。总体上，根据数据显示，2018年FIGO系统相对于2009年FIGO系统的5年无进展生存率分别为：分期I为80%与87%（P=0.）。"
}